These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7662389)

  • 1. Left ventricular dysfunction after acute myocardial infarction.
    Perdigão C
    Rev Port Cardiol; 1995 Jun; 14(6):493-7. PubMed ID: 7662389
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of nitrates in left ventricular insufficiency in patients with acute myocardial infarction].
    Maggioni AP
    G Ital Cardiol; 1996 Sep; 26(9):1095-8. PubMed ID: 9036052
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neoton and thrombolytic therapy of myocardial infarction].
    Perepech NB; Nedoshivin AO; Nesterova IV
    Ter Arkh; 2001; 73(9):50-5. PubMed ID: 11642083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute myocardial infarct and left ventricular dysfunction. Morphologic bases, clinical aspects and pharmacologic prevention].
    Perdigão C
    Acta Med Port; 1996; 9(2-3):113-9. PubMed ID: 8967304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Real benefits shown by large clinical studies on thrombolysis in acute myocardial infarction].
    Casaccia M; Scacciatella P
    G Ital Cardiol; 1997 Dec; 27(12):1337-43. PubMed ID: 9470071
    [No Abstract]   [Full Text] [Related]  

  • 6. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
    MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk stratification for malignant arrhythmias after myocardial infarction. A reappraisal in the era of thrombolysis.
    González-Hermosillo González JA
    Arch Inst Cardiol Mex; 1997; 67(3):183-5. PubMed ID: 9294660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
    Mazzotta G; Vecchio C
    G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the antihypertensive agent Diovan after acute myocardial infarction].
    Rev Med Suisse; 2005 Jun; 1(26):1726-7. PubMed ID: 16117045
    [No Abstract]   [Full Text] [Related]  

  • 10. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term significance of Killip class and left ventricular systolic dysfunction.
    Parakh K; Thombs BD; Bhat U; Fauerbach JA; Bush DE; Ziegelstein RC
    Am J Med; 2008 Nov; 121(11):1015-8. PubMed ID: 18954850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of beta-blockers during and after myocardial infarction.
    Aronow WS
    Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction.
    Parissis JT; Adamopoulos S; Venetsanou K; Kostakis G; Rigas A; Karas SM; Kremastinos D
    Eur Cytokine Netw; 2004; 15(2):139-44. PubMed ID: 15319174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction.
    Ishihara M; Inoue I; Kawagoe T; Shimatani Y; Kurisu S; Nishioka K; Umemura T; Nakamura S; Yoshida M
    Am Heart J; 2003 Oct; 146(4):674-8. PubMed ID: 14564322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suboptimal results of Optimaal: treatment with ACE inhibitors remains the preferred therapy in patients with left ventricular dysfunction after acute myocardial infarct]].
    Danchin N
    Herz; 2002 Dec; 27(8):(18). PubMed ID: 12608391
    [No Abstract]   [Full Text] [Related]  

  • 16. Streptokinase in acute myocardial infarction.
    Rajagopalan RS
    J Assoc Physicians India; 1993 Jun; 41(6):325-6. PubMed ID: 8005961
    [No Abstract]   [Full Text] [Related]  

  • 17. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
    Engberding N; Spiekermann S; Schaefer A; Heineke A; Wiencke A; Müller M; Fuchs M; Hilfiker-Kleiner D; Hornig B; Drexler H; Landmesser U
    Circulation; 2004 Oct; 110(15):2175-9. PubMed ID: 15466649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction.
    Zhang Y; Wang L
    Med Hypotheses; 2006; 67(5):1076-8. PubMed ID: 16697117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.
    Brodie BR; Stuckey TD; Hansen C; Bradshaw BH; Downey WE; Pulsipher MW
    Am J Cardiol; 2007 Feb; 99(4):431-5. PubMed ID: 17293178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolytic therapy in acute myocardial infarct. The facts and the statistical ideal].
    Baruzzi AC; Knobel E; Cirenza C; Fehér J
    Arq Bras Cardiol; 1994 Aug; 63(2):87-9. PubMed ID: 7661716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.